The immunotoxicity of graphene oxides and the effect of PVP-coating

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5254-5261

  Zhi, Xiao ^a   Fang, Hongliang ^b,c   Bao, Chenchen ^a   Shen, Guangxia ^a   Zhang, Jiali ^a   Wang, Kan ^a   Guo, Shouwu ^a   Wan, Tao ^b   Cui, Daxiang ^a  

^a Shanghai Jiao Tong University   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dendritic cells; Graphene oxide; Immunotoxicity; Macrophages; PVP; T lymphocytes

Indexed keywords

DENDRITIC CELLS; GRAPHENE OXIDES; IMMUNOTOXICITY; PVP; T LYMPHOCYTES;

ANTIGEN-ANTIBODY REACTIONS; BIOCOMPATIBILITY; GRAPHENE; LYMPHOCYTES; MACROPHAGES; PHYSIOLOGY;

COATINGS;

GRAPHENE OXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; POVIDONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTOXICITY; IN VITRO STUDY; MACROPHAGE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; COATED MATERIALS, BIOCOMPATIBLE; CYTOKINES; DENDRITIC CELLS; GRAPHITE; HUMANS; IMMUNOTOXINS; MACROPHAGES; MICROSCOPY, ATOMIC FORCE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDES; PHENOTYPE; POVIDONE; T-LYMPHOCYTES;

EID: 84877072302     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.024     Document Type: Article

References (56)

1. Geim A.K., Novoselov K.S. The rise of graphene. Nat Mater 2007, 6:183-191.
2. Kopelevich Y., Esquinazi P. Graphene physics in graphite. Adv Mater 2007, 19:4559-4563.
3. Wu C.Y., Zhang Y., Wu X.C., Yang Y.Q., Zhou X.J., Wu H.X. Biological applications of graphene and graphene oxide. Nano Biomed Eng 2012, 4:157-162.
4. Shan C.S., Yang H.F., Song J.F., Han D.X., Ivaska A., Niu L. Direct electrochemistry of glucose oxidase and biosensing for glucose based on graphene. Anal Chem 2009, 81:2378-2382.
5. Shao Y.Y., Wang J., Wu H., Liu J., Aksay I.A., Lin Y.H. Graphene based electrochemical sensors and biosensors: a review. Electroanalysis 2010, 22:1027-1036.
6. Pumera M., Scipioni R., Iwai H., Ohno T., Miyahara Y., Boero M. Amechanism of adsorption of beta-nicotinamide adenine dinucleotide on graphene sheets: experiment and theory. Chem Eur J 2009, 15:10851-10856.
7. Schedin F., Geim A., Morozov S., Hill E., Blake P., Katsnelson M., et al. Detection of individual gas molecules adsorbed on graphene. Nat Mater 2007, 6:652-655.
8. Sakhaee-Pour A., Ahmadian M., Vafai A. Potential application of single-layered graphene sheet as strain sensor. Solid State Commun 2008, 147:336-340.
9. Li D., Muller M.B., Gilje S., Kaner R.B., Wallace G.G. Processable aqueous dispersions of graphene nanosheets. Nat Nanotechnol 2008, 3:101-105.
10. Yang X., Wang Y., Huang X., Ma Y., Huang Y., Yang R., et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. JMater Chem 2010, 3448-3454.
11. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. JAm Chem Soc 2008, 130:10876-10877.
12. Zhang L.M., Xia J.G., Zhao Q.H., Liu L.W., Zhang Z.J. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6:537-544.
13. Zhang L., Lu Z., Zhao Q., Huang J., Shen H., Zhang Z. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 2011, 7:460-464.
14. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
15. Huang P., Lin J., Wang X.S., Wang Z., Zhang C.L., He M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 2012, 24:5104-5110.
16. Wang K., Ruan J., Song H., Zhang J.L., Wo Y., Guo S.W., et al. Biocompatibility of graphene oxide. Nanoscale Res Lett 2011, 6:1-8.
17. Vallabani N.V.S., Mittal S., Shukla R.K., Pandey A.K., Dhakate S.R., Pasricha R., et al. Toxicity of graphene in normal human lung cells (BEAS-2B). JBiomed Nanotechnol 2011, 7:106-107.
18. Singh S.K., Singh M.K., Nayak M.K., Kumari S., Gracio J.J.A., Dash D. Characterization of graphene oxide by flow cytometry and assessment of its cellular toxicity. JBiomed Nanotechnol 2011, 7:30-31.
19. Kim S.-M., Joo P., Ahn G., Cho I.H., Kim D.H., Song W.K., et al. Transparent conducting films based on reduced graphene oxide multilayers for biocompatible neuronal interfaces. JBiomed Nanotechnol 2013, 9:403-408.
20. Von Recum A. Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials 1999, CRC Press.
21. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
22. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
23. Dieu-Nosjean M.C., Vicari A., Lebecque S., Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. JLeukoc Biol 1999, 66:252-262.
24. Hummers W.S., Offeman R.E. Preparation of graphitic oxide. JAm Chem Soc 1958, 80:1339.
25. Titelman G., Gelman V., Bron S., Khalfin R., Cohen Y., Bianco-Peled H. Characteristics and microstructure of aqueous colloidal dispersions of graphite oxide. Carbon 2005, 43:641-649.
26. Wang X.S., Huang P., Feng L.L., He M., Guo S.W., Shen G.X., et al. Green controllable synthesis of silver nanomaterials on graphene oxide sheets via spontaneous reduction. RSC Adv 2012, 2:3816-3822.
27. Wang X.S., Yang D.P., Huang G.S., Huang P., Shen G.X., Guo S.W., et al. Rolling up graphene oxide sheets into micro/nanoscrolls by nanoparticle aggregation. JMater Chem 2012, 22:17441-17444.
28. Zhang J.L., Yang H.J., Shen G.X., Cheng P., Zhang J.Y., Guo S.W. Reduction of graphene oxide via L-ascorbic acid. Chem Commun 2010, 46:1112-1114.
29. Zhang J.L., Shen G.X., Wang W.J., Zhou X.J., Guo S.W. Individual nanocomposite sheets of chemically reduced graphene oxide and poly(N-vinyl pyrrolidone): preparation and humidity sensing characteristics. JMater Chem 2010, 20:10824-10828.
30. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. JExp Med 1994, 179:1109-1118.
31. Ferrari M., Fornasiero M.C., Isetta A.M. MTT colorimetric assay for testing macrophage cytotoxic activity invitro. JImmunol Methods 1990, 131:165-172.
32. Pozzolini M., Scarfi S., Benatti U., Giovine M. Interference in MTT cell viability assay in activated macrophage cell line. Anal Biochem 2003, 313:338-341.
33. Zhou L.J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. JImmunol 1995, 154:3821-3835.
34. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J.M., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. JImmunol 1999, 163:57-61.
35. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
36. Demedts I.K., Brusselle G.G., Vermaelen K.Y., Pauwels R.A. Identification and characterization of human pulmonary dendritic cells. Am J Resp Cell Mol 2005, 32:177-184.
37. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992, 258-261.
38. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
39. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. JExp Med 1998, 188:373-386.
40. Lanzavecchia A., Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001, 13:291-298.
41. Zlotnik A., Yoshie O. Chemokines: a new classification review system and their role in immunity. Immunity 2000, 12:121-127.
42. Ciaramella A., Spalletta G., Bizzoni F., Salani F., Caltagirone C., Bossu P. Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell Immunol 2011, 269:82-89.
43. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002, 13:357-368.
44. Lin W.W., Karin M. Acytokine-mediated link between innate immunity, inflammation, and cancer. JClin Invest 2007, 117:1175-1183.
45. Pang G., Couch L., Batey R., Clancy R., Cripps A. GM-CSF, IL-1a, IL-1b, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1a and TNF-a. Clin Exp Immunol 1994, 96:437-443.
46. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456.
47. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
48. Kumar S., Lavin M. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ 1996, 3:255-267.
49. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993, 14:131-136.
50. Lenardo M., Chan F.K.M., Hornung F., McFarland H., Siegel R., Wang J., et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999, 17:221-253.
51. Russell J.H., White C.L., Loh D.Y., Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A 1991, 88:2151-2155.
52. Kabelitz D., Pohl T., Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993, 14:338-339.
53. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T., et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994, 1:131-136.
54. Alderson M.R., Tough T.W., Davis-Smith T., Braddy S., Falk B., Schooley K.A., et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. JExp Med 1995, 181:71-77.
55. Strasser A., Harris A., Huang D., Krammer P., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995, 14:6136-6147.
56. Ruiz O.N., Fernando K.A.S., Wang B., Brown N.A., Luo P.G., McNamara N.D., et al. Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano 2011, 5:8100-8107.